https://pharmoniq.com/news/cycle-pharmaceuticals-halts-govorestat-cmt-sord-trials PharmoniQ en 2026-04-26T14:10:49.085Z Cycle Pharma Terminates Govorestat Development for Rare CMT Disease clinical trials, rare disease, CMT, govorestat, drug development https://pharmoniq.com/news/grace-therapeutics-bleeding-stroke-drug-fda-rejection-2024 PharmoniQ en 2026-04-26T08:47:01.879Z Grace Therapeutics' Stroke Drug Rejected by FDA, Shares Fall 45% FDA approval, stroke treatment, biotechnology, clinical trials, regulatory affairs https://pharmoniq.com/news/amneal-acquires-kashiv-biosciences-biosimilars-expansion PharmoniQ en 2026-04-25T14:10:49.850Z Amneal Acquires Kashiv BioSciences for $1.1B in Biosimilars Push biosimilars, mergers-acquisitions, amneal-pharmaceuticals, biologics, market-expansion https://pharmoniq.com/news/pbm-reform-legislation-reshape-pharmacy-business-models PharmoniQ en 2026-04-25T08:47:02.271Z PBM Reform Legislation Set to Reshape Pharmacy Business Models PBM reform, pharmacy reimbursement, healthcare policy, pharmacy business models, drug pricing